In Ottawa we have a lot of very bright basic scientists who have a tendency to want to focus in on the one little aspect they're working on. I think they lose track of what the bigger focus is, and sometimes they lose track of the applicability of what they're doing. So one of the things we've been able to do in Ottawa is to provide seed money for researchers doing other things, and tie them into Parkinson's.
I think one of our ideas on a more national basis is to really try to bring people together who have very good ideas and who are working on very exciting things, and to make sure those things have clinical applicability. It's amazing how many scientists are out there doing a fantastic job in their very small area, while it has much wider applicability than, I think, they currently think it does.
This is one of the areas in which we could do a much better job on a national basis, really bringing more people together to share ideas, to say “You know how to do that. That's fantastic. Could we tap into that? Because I have this idea, and we could use your experiments to help us do this kind of thing.” This collaborative effort would speed things up a great deal.